PL437793A1 - Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum) - Google Patents

Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)

Info

Publication number
PL437793A1
PL437793A1 PL437793A PL43779321A PL437793A1 PL 437793 A1 PL437793 A1 PL 437793A1 PL 437793 A PL437793 A PL 437793A PL 43779321 A PL43779321 A PL 43779321A PL 437793 A1 PL437793 A1 PL 437793A1
Authority
PL
Poland
Prior art keywords
application
bovine colostrum
butter obtained
ghee
ghee butter
Prior art date
Application number
PL437793A
Other languages
English (en)
Inventor
Michał Łusiak
Jakub FICHNA
Maciej Sałaga
Marcin Talar
Paula Mosińska
Aleksandra Tarasiuk
Julia Krajewska
Adam Fabisiak
Agata Binienda
Adrian Bartoszek
Katarzyna Dziedziczak
Karolina Niewinna
Original Assignee
Uniwersytet Medyczny w Łodzi
Łusiak Michał Przedsiębiorstwo Wielobranżowe Proszki Mleczne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny w Łodzi, Łusiak Michał Przedsiębiorstwo Wielobranżowe Proszki Mleczne filed Critical Uniwersytet Medyczny w Łodzi
Priority to PL437793A priority Critical patent/PL437793A1/pl
Priority to CZ2022-188A priority patent/CZ309662B6/cs
Publication of PL437793A1 publication Critical patent/PL437793A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem wynalazku jest masło Ghee otrzymywane z siary bydlęcej (colostrum) do zastosowania w profilaktyce i leczeniu chorób jelit.
PL437793A 2021-05-07 2021-05-07 Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum) PL437793A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL437793A PL437793A1 (pl) 2021-05-07 2021-05-07 Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)
CZ2022-188A CZ309662B6 (cs) 2021-05-07 2022-05-06 Použití ghí másla získaného z kravského mleziva, kolostra

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL437793A PL437793A1 (pl) 2021-05-07 2021-05-07 Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)

Publications (1)

Publication Number Publication Date
PL437793A1 true PL437793A1 (pl) 2022-11-14

Family

ID=83997714

Family Applications (1)

Application Number Title Priority Date Filing Date
PL437793A PL437793A1 (pl) 2021-05-07 2021-05-07 Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)

Country Status (2)

Country Link
CZ (1) CZ309662B6 (pl)
PL (1) PL437793A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
AU2017220388A1 (en) * 2016-02-16 2018-08-16 Atp Institute Pty Ltd Formulation and method of use
CN109619140A (zh) * 2019-02-02 2019-04-16 祁连播森农牧科技开发有限公司 一种含有酥油的有机营养曲奇饼干及其制备方法

Also Published As

Publication number Publication date
CZ2022188A3 (cs) 2022-11-16
CZ309662B6 (cs) 2023-06-21

Similar Documents

Publication Publication Date Title
Cho et al. Lipopolysaccharide induces pro-inflammatory cytokines and MMP production via TLR4 in nasal polyp-derived fibroblast and organ culture
CO2021000326A2 (es) Composiciones y métodos para aumentar o mejorar la transducción de vectores de terapia genética y para eliminar o reducir las inmunoglobulinas
CL2021000343A1 (es) Inhibidores peptídicos del receptor de interleucina 23 (divisional de la solicitud n° 201800128)
ECSP21093541A (es) Compuestos para el tratamiento de enfermedades y trastornos asociados con braf
CL2020002019A1 (es) Composiciones para modular la expresión de c9orf72. (divisional solicitud 201803582)
MA53496A (fr) Combinaisons pour le traitement de la stéatohépatite non alcoolique (nash)/maladie du foie gras non alcoolique (nafld) et de maladies associées
BR112022000875A2 (pt) Métodos e produtos para tratamento de distúrbios gastrointestinais
BR112018014633A2 (pt) vetor de terapia gênica e métodos de prevenção, mitigação, melhoramento, redução, inibição, eliminação e/ ou reversão de um ou mais sintomas da doença de danon
BR112018014222A2 (pt) método de tratamento da glomerulopatia c3
CL2024000099A1 (es) Inhibidores peptídicos lipidados del receptor de interleucina-23.
BR112022015416A2 (pt) Anticorpos anti-ror1 e composições
CY1125104T1 (el) Συνθεσεις φλαγελλινης entrecoccus για χρηση στη θεραπεια
EA202190310A1 (ru) Белок для лечения воспалительных заболеваний
MX2020013120A (es) Tratamiento terapéutico de cánceres de microsatélites inestables.
CO2022010592A2 (es) Métodos de tratamiento de la esplenomegalia
MX2022012692A (es) Composiciones que comprenden nanoparticulas, metodo de elaboracion y usos de las mismas.
MX2023009723A (es) Inhibidores de tyk2 y sus usos.
PL437793A1 (pl) Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)
EA202191686A1 (ru) Гидролизат коллагена для применения против кожных болезней и кишечных заболеваний
MX2021010766A (es) Anticuerpos que se unen a la proteína del gen 6 inducible por el factor de necrosis tumoral (tsg-6) y usos de estos.
MX2020013100A (es) Metodos de uso de cd24 para la prevencion y tratamiento de enfermedad de injerto contra hospedero y mucositis.
MX2023009681A (es) Composiciones de anticuerpos anti-tl1a y metodos de tratamiento en el pulmon.
EA202190057A1 (ru) Солюбилизированные апиразы, способы и применение
MX2020009496A (es) Metodo para tratar asma o enfermedad alergica.
BR112021021839A2 (pt) Composições imunomodulatórias e métodos